Developer docs
API playgroundTry for free, no card

Search company profiles

Pharmaceutical Care Management Association

Full company profile

uuid000j9z8

Namestring
Pharmaceutical Care Management Association
Legal namestring
Pharmaceutical Care Management Association
Websiteurl
pcmanet.org
Company typeenum
Private
Founded yearint
1975
Descriptiontext

The Pharmaceutical Care Management Association (PCMA) is a Washington, D.C.-based national trade association founded in 1975 that serves as the collective policy and lobbying vehicle for the U.S. pharmacy benefit manager (PBM) industry. PCMA represents the largest PBMs operating in the United States — CVS Caremark, Express Scripts, and OptumRx — which together control approximately 80% of the U.S. prescription drug market. The organization operates as a nonprofit funded by member dues from these PBM companies rather than by commercial product sales.

PCMA does not develop or sell commercial technology products. Instead, its core function is regulatory and legal advocacy on behalf of the PBM industry. Its activities include direct federal and state lobbying, federal litigation to challenge state PBM laws, industry research and communications, and public campaigns aimed at shaping legislation around drug pricing transparency, pharmacy ownership restrictions, vertical integration, and antitrust scrutiny. The organization has spent $47 million on lobbying against PBM reform since 2023 and has launched a seven-figure advertising campaign to influence public and legislative opinion.

PCMA's business model is a member-dues-funded trade association structure. Its customers are its PBM member companies, and its value proposition is collective representation in regulatory and legal forums that individual PBMs could not efficiently pursue alone. With a lean staff of 11–50 employees, the association concentrates its resources on a small number of high-impact legal and lobbying engagements, most recently the Tennessee FAIR Rx Act lawsuit and the Illinois Prescription Drug Affordability Act lawsuit. Its commercial significance lies in shaping the regulatory environment that determines the profitability and operating latitude of the PBM industry rather than in any direct revenue-generating activity.

Short descriptiontext

PCMA is the Washington, D.C.-based national trade association that represents the U.S. pharmacy benefit manager (PBM) industry through federal and state lobbying, legal advocacy, and policy communications on behalf of its PBM member companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmacy benefit management, trade association advocacy, healthcare lobbying, pharmaceutical policy, PBM representation
Industry3 codes
1Formulary Management & Clinical Pharmacy Programs
CodeHLAEAKAAPrimaryYes
2Pharmacy Benefit Management (PBM) & Pharmacy Network Administration
CodeHLAFALAIPrimaryNo
3Prior Authorization, Utilization Management & Step Therapy
CodeHLAEAKAGPrimaryNo
NAICS code1 code
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
Product category
Pharmaceutical Trade Association Services
Social media profiles3 records
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Cost components4 values
Marketing or Sales, Operations, Others, Personnel
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PCMA is a national trade association representing pharmacy benefit managers (PBMs). It provides regulatory advocacy, legislative lobbying, legal defense against state and federal PBM regulations, industry research, and policy development on behalf of its PBM member companies, which include CVS Caremark, Express Scripts, and OptumRx.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The Pharmaceutical Care Management Association (PCMA) is a national trade association and industry lobby representing pharmacy benefit managers (PBMs). Rather than offering commercial technology products or services, PCMA functions as an industry advocacy organization that represents the interests of PBM companies in regulatory, legislative, and legal matters. The organization engages in lobbying activities, files lawsuits on behalf of member PBMs, and publishes industry research and policy positions.

Product and service4 records
1Trade Association Membership
CategoryTrade Association
2Regulatory Advocacy and Lobbying Services
CategoryGovernment Relations
3Legal Defense Services
CategoryLegal Services
4Industry Communications and Public Affairs
CategoryCommunications
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers8 records
1America's Health Insurance Plans
TypeDirect peer
Description

AHIP is the national trade association representing health insurers, many of whom are PCMA's counterparties on drug benefit administration. Both organizations operate as DC-based healthcare policy advocacy groups with overlapping lobbying portfolios.

2Biotechnology Innovation Organization
TypeBroad incumbent
Description

BIO is a large life sciences trade association that, like PCMA, conducts extensive federal lobbying on drug pricing, IP, and reimbursement. It is comparable as a larger healthcare/pharma policy advocacy body, though its members are manufacturers rather than PBMs.

3Academy of Managed Care Pharmacy
TypeDirect peer
Description

AMCP is a professional association for managed care pharmacists, with significant overlap with PBM operations including formulary management and utilization review — areas central to PCMA's advocacy portfolio.

4Pharmaceutical Research and Manufacturers of America
TypeDirect peer
Description

PhRMA is the national trade association representing the pharmaceutical/biopharmaceutical industry, making it the closest structural analog to PCMA as a healthcare sector trade and lobbying organization.

5National Community Pharmacists Association
TypeDirect peer
Description

NCPA represents independent community pharmacists and frequently litigates and lobbies on PBM reimbursement and steering practices, making it a directly comparable pharmacy-focused trade and advocacy organization.

6National Association of Chain Drug Stores
TypeDirect peer
Description

NACDS represents retail pharmacy chains and is frequently on the opposing side of PBM policy debates. As a pharmacy-sector trade association engaged in PBM-related lobbying and litigation, it is directly comparable in mission and structure.

7Healthcare Distribution Alliance
TypeDirect peer
Description

HDA represents pharmaceutical distributors and engages in drug supply chain policy advocacy, sharing PCMA's healthcare trade association structure and DC-based lobbying approach.

8American Society of Health-System Pharmacists
TypeDirect peer
Description

ASHP is a national pharmacy professional association that engages in advocacy on drug pricing, 340B, and PBM issues, providing a comparable pharmacy-sector lobbying and member-services model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharmaceutical Care Management Association

Pharmaceutical Trade Association Servicespcmanet.org

PCMA is the Washington, D.C.-based national trade association that represents the U.S. pharmacy benefit manager (PBM) industry through federal and state lobbying, legal advocacy, and policy communications on behalf of its PBM member companies.

What Pharmaceutical Care Management Association does

The Pharmaceutical Care Management Association (PCMA) is a Washington, D.C.-based national trade association founded in 1975 that serves as the collective policy and lobbying vehicle for the U.S. pharmacy benefit manager (PBM) industry. PCMA represents the largest PBMs operating in the United States — CVS Caremark, Express Scripts, and OptumRx — which together control approximately 80% of the U.S. prescription drug market. The organization operates as a nonprofit funded by member dues from these PBM companies rather than by commercial product sales.

PCMA does not develop or sell commercial technology products. Instead, its core function is regulatory and legal advocacy on behalf of the PBM industry. Its activities include direct federal and state lobbying, federal litigation to challenge state PBM laws, industry research and communications, and public campaigns aimed at shaping legislation around drug pricing transparency, pharmacy ownership restrictions, vertical integration, and antitrust scrutiny. The organization has spent $47 million on lobbying against PBM reform since 2023 and has launched a seven-figure advertising campaign to influence public and legislative opinion.

PCMA's business model is a member-dues-funded trade association structure. Its customers are its PBM member companies, and its value proposition is collective representation in regulatory and legal forums that individual PBMs could not efficiently pursue alone. With a lean staff of 11–50 employees, the association concentrates its resources on a small number of high-impact legal and lobbying engagements, most recently the Tennessee FAIR Rx Act lawsuit and the Illinois Prescription Drug Affordability Act lawsuit. Its commercial significance lies in shaping the regulatory environment that determines the profitability and operating latitude of the PBM industry rather than in any direct revenue-generating activity.

Pharmaceutical Care Management Association firmographics

Firmographics
Name
Pharmaceutical Care Management Association
Legal name
Pharmaceutical Care Management Association
Website
https://pcmanet.org
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
11–50 employees
Short description
PCMA is the Washington, D.C.-based national trade association that represents the U.S. pharmacy benefit manager (PBM) industry through federal and state lobbying, legal advocacy, and policy communications on behalf of its PBM member companies.
Ownership category
akta.pro rank

Pharmaceutical Care Management Association industry classification

Industry
Product category
Pharmaceutical Trade Association Services
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
akta.pro primary industry
Formulary Management & Clinical Pharmacy Programs (HLAEAKAA)
akta.pro secondary industries
Pharmacy Benefit Management (PBM) & Pharmacy Network Administration (HLAFALAI), Prior Authorization, Utilization Management & Step Therapy (HLAEAKAG)

Keywords

  • Pharmacy benefit management
  • Trade association advocacy
  • Healthcare lobbying
  • Pharmaceutical policy
  • PBM representation

Where Pharmaceutical Care Management Association is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Markets served

Pharmaceutical Care Management Association business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Marketing or Sales, Operations, Others, Personnel

Marketing channels3 records

Pharmaceutical Care Management Association product offering

Product offering

Core offering

PCMA is a national trade association representing pharmacy benefit managers (PBMs). It provides regulatory advocacy, legislative lobbying, legal defense against state and federal PBM regulations, industry research, and policy development on behalf of its PBM member companies, which include CVS Caremark, Express Scripts, and OptumRx.

Product overview

The Pharmaceutical Care Management Association (PCMA) is a national trade association and industry lobby representing pharmacy benefit managers (PBMs). Rather than offering commercial technology products or services, PCMA functions as an industry advocacy organization that represents the interests of PBM companies in regulatory, legislative, and legal matters. The organization engages in lobbying activities, files lawsuits on behalf of member PBMs, and publishes industry research and policy positions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Trade Association Membership
  • Regulatory Advocacy and Lobbying Services
  • Legal Defense Services
  • Industry Communications and Public Affairs

Companies that use Pharmaceutical Care Management Association

Customer profile

Segments1 record

Ideal customer profiles1 record

Pharmaceutical Care Management Association technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pharmaceutical Care Management Association partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Pharmaceutical Care Management Association competitors and assessment

Company assessment

Direct peers

  • America's Health Insurance Plans: AHIP is the national trade association representing health insurers, many of whom are PCMA's counterparties on drug benefit administration. Both organizations operate as DC-based healthcare policy advocacy groups with overlapping lobbying portfolios.
  • Academy of Managed Care Pharmacy: AMCP is a professional association for managed care pharmacists, with significant overlap with PBM operations including formulary management and utilization review — areas central to PCMA's advocacy portfolio.
  • Pharmaceutical Research and Manufacturers of America: PhRMA is the national trade association representing the pharmaceutical/biopharmaceutical industry, making it the closest structural analog to PCMA as a healthcare sector trade and lobbying organization.
  • National Community Pharmacists Association: NCPA represents independent community pharmacists and frequently litigates and lobbies on PBM reimbursement and steering practices, making it a directly comparable pharmacy-focused trade and advocacy organization.
  • National Association of Chain Drug Stores: NACDS represents retail pharmacy chains and is frequently on the opposing side of PBM policy debates. As a pharmacy-sector trade association engaged in PBM-related lobbying and litigation, it is directly comparable in mission and structure.
  • Healthcare Distribution Alliance: HDA represents pharmaceutical distributors and engages in drug supply chain policy advocacy, sharing PCMA's healthcare trade association structure and DC-based lobbying approach.
  • American Society of Health-System Pharmacists: ASHP is a national pharmacy professional association that engages in advocacy on drug pricing, 340B, and PBM issues, providing a comparable pharmacy-sector lobbying and member-services model.

Broad incumbents

  • Biotechnology Innovation Organization: BIO is a large life sciences trade association that, like PCMA, conducts extensive federal lobbying on drug pricing, IP, and reimbursement. It is comparable as a larger healthcare/pharma policy advocacy body, though its members are manufacturers rather than PBMs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

Pharmaceutical Care Management Association social profiles

Digital presence

Pharmaceutical Care Management Association financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharmaceutical Care Management Association leadership team

Management profile

Number of profiles

Profiles1 record

Pharmaceutical Care Management Association funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharmaceutical Care Management Association M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaceutical Care Management Association

What does Pharmaceutical Care Management Association do?

PCMA is a national trade association representing pharmacy benefit managers (PBMs). It provides regulatory advocacy, legislative lobbying, legal defense against state and federal PBM regulations, industry research, and policy development on behalf of its PBM member companies, which include CVS Caremark, Express Scripts, and OptumRx.

Is Pharmaceutical Care Management Association a public or private company?

Pharmaceutical Care Management Association is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Pharmaceutical Care Management Association founded?

Pharmaceutical Care Management Association was founded in 1975. It employs 11 to 50 people.

Where is Pharmaceutical Care Management Association based?

Pharmaceutical Care Management Association is headquartered in Washington, United States, in the North America region.

Who are Pharmaceutical Care Management Association's main competitors?

Direct peers on record are America's Health Insurance Plans, Academy of Managed Care Pharmacy, Pharmaceutical Research and Manufacturers of America, National Community Pharmacists Association, National Association of Chain Drug Stores, Healthcare Distribution Alliance and American Society of Health-System Pharmacists. Biotechnology Innovation Organization is listed as a broad incumbent.

Does Pharmaceutical Care Management Association have an API?

No public API is recorded for Pharmaceutical Care Management Association.

What industry is Pharmaceutical Care Management Association in?

Pharmaceutical Care Management Association's product category is Pharmaceutical Trade Association Services. Its primary akta.pro industry code is HLAEAKAA, Formulary Management & Clinical Pharmacy Programs, with a secondary code of HLAFALAI, Pharmacy Benefit Management (PBM) & Pharmacy Network Administration. Its NAICS code is 524292.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Inc.Why Nearly Half of U.S. Businesses Are Suddenly Ditching Big Pharmacy ManagersEmployers are increasingly shifting away from the three largest pharmacy benefit managers (PBMs) to smaller alternatives or new transparency-focused platforms like TrumpRx in response to rising healthcare premiums. This trend is supported by an agreement finalized by the Pharmaceutical Care Management Association (PCMA), requiring nine major U.S. PBMs to disclose pricing data for medication purchases.Tennessee LookoutMore PBMs file lawsuits against Tennessee over bill banning ownership of stores • Tennessee LookoutExpress Scripts and the Pharmaceutical Care Management Association have filed separate lawsuits against the state of Tennessee over legislation, known as the Fair Rx Act, that bans pharmacy benefit managers from owning pharmacies — bringing the total number of legal challenges against the law signed by Gov. Bill Lee in May to three. The bill followed a state audit that found PBMs were reimbursing their affiliated pharmacies at significantly higher rates than non-affiliated ones. A similar ban passed in Arkansas in 2025 was blocked by a federal judge who ruled it likely violated the U.S. Constitution's Commerce Clause.PR NewswireRxPreferred Responds to Inaccurate Claims Linking the Company to Tennessee PBM LawsuitsRxPreferred, an independent pharmacy benefit administrator, issued a statement clarifying that it is not a party to lawsuits filed by the Pharmaceutical Care Management Association challenging Tennessee's PBM vertical integration ban, despite being referenced by name in those proceedings. The company supports Tennessee's FAIR Rx Act and emphasizes its zero-conflict-of-interest business model, distinguishing itself from vertically integrated PBMs that own pharmacies or insurers. RxPreferred views stronger PBM regulation as aligned with its founding principles of transparency and independence.Insurance Business AmericaIllinois drug-pricing law draws ERISA preemption suit from national PBM trade groupThe Pharmaceutical Care Management Association, the national trade group for pharmacy benefit managers, filed suit on June 16, 2026, against the Illinois Department of Insurance to challenge the Illinois Prescription Drug Affordability Act, signed into law on July 1, 2025. The PCMA argues the law is preempted by ERISA, citing the 2016 Supreme Court ruling in Gobeille v. Liberty Mutual Insurance Co., and seeks to block two provisions: a detailed annual reporting requirement with potential fines of up to $10,000 per day for non-compliance, and a ban on "steering" patients toward affiliated pharmacies through plan designs that increase costs. The trade group wants both provisions declared invalid and permanently blocked from enforcement for ERISA-covered plans, which it estimates cover about two-thirds of employer- and union-sponsored plans.Healthcare DivePCMA sues to exempt PBMs from Illinois drug lawThe Pharmaceutical Care Management Association (PCMA), the primary PBM industry lobby, filed a federal lawsuit against the Illinois Department of Insurance on Tuesday seeking to exempt pharmacy benefit managers from the state\'s Prescription Drug Affordability Act (PDAA). The PDAA, signed by Gov. J.B. Pritzker last July, requires PBMs to disclose granular drug pricing data—including transaction-level payments and manufacturer rebates—to the Illinois Department of Insurance and payer customers, and bans PBMs from designing networks that steer patients toward their own in-house pharmacies. The PCMA argues both provisions are preempted by ERISA, the federal law governing employee benefit plans, and is asking the court to declare the requirements inapplicable to PBMs serving employer-sponsored plans.YahooPCMA sues to exempt PBMs from Illinois drug lawThe Pharmaceutical Care Management Association filed a federal lawsuit against the Illinois Department of Insurance to exempt pharmacy benefit managers from the state's Prescription Drug Affordability Act, arguing the law clashes with federal oversight of employee benefit plans.FierceHealthcarePCMA joins major PBMs in suing over Tennessee's new PBM lawThe Pharmaceutical Care Management Association has joined CVS Health and Express Scripts in filing lawsuits to challenge Tennessee's new FAIR Rx Act, which bars pharmacy benefit managers from owning or being affiliated with pharmacies operating in the state. The PBMs argue the law is unconstitutional and will force the closure of more than 160 pharmacy locations, create pharmacy deserts in rural areas where over a third of residents currently rely on these services, limit patient access to medications including specialty and mail-order drugs, and increase drug costs for Tennessee employers by more than $180 million annually. The Tennessee Pharmacists Association supports the law, arguing it brings greater transparency and fairness to the market and protects independent pharmacies from what they characterize as greedy corporate interests.Managed Healthcare ExecutiveHouse passes funding bill that includes PBM reformThe House of Representatives passed the Consolidated Appropriations Act 2026 (H.R. 7148), which includes significant reforms targeting pharmacy benefit managers (PBMs), including prohibiting PBM compensation in Medicare Part D from being tied to drug manufacturer list prices and requiring PBMs to pass all rebates and discounts to plan sponsors. The bill provides $188 million to CMS for enforcement and establishes an appeals process for pharmacies to dispute contract terms deemed unreasonable, representing the first major PBM reform in Medicare Part D in nearly 20 years. Industry groups have mixed reactions, with pharmacist organizations including the National Community Pharmacists Association and the National Association of Chain Drug Stores welcoming the reforms as long overdue, while the Pharmaceutical Care Management Association warns the measures will be costly and lead to higher drug costs and premiums.BioXconomyPBM reform mandates transparency and rebate changesBrendan Buck, chief communications officer at the Pharmaceutical Care Management Association, described recently passed PBM reform legislation as the most significant reform to the industry in a long time, during a healthcare policy panel. The law mandates full transparency in PBM operations and requires complete rebate pass-through to employers, fundamentally altering the PBM business model and creating new financial and administrative responsibilities. Buck expressed skepticism that PBM reforms alone will resolve healthcare affordability issues, citing broader structural changes as necessary, while highlighting Express Scripts' $25 insulin collaboration as a model for manufacturer-PBM partnerships.MedCity NewsWill Tennessee’s PBM Bill Face the Same Fate as Arkansas’ Law?Tennessee lawmakers passed the FAIR Rx Act, which would ban PBMs from owning pharmacies, with a 24-9 Senate and 86-7 House vote. The bill awaits Governor Bill Lee's signature, and CVS and Optum Rx have said they will challenge its constitutionality. A judge in Arkansas previously blocked a similar law under the Commerce Clause.